日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Food Insecurity Interventions to Improve Blood Pressure: The Healthy Food First Factorial Randomized Clinical Trial

改善血压的食品安全干预措施：健康食品优先析因随机临床试验

期刊:Jama Internal Medicine
影响因子:
doi:10.1001/jamainternmed.2025.5287
Berkowitz, Seth A; Ammerman, Alice S; Knoepp, Patricia; Anderson, Robert E 3rd; Taylor, Lori H; Jedele, Jenefer M; Archibald, Jessica; Xue, Keyi; Wertman, Eleanor; Dellva, Benjamin; Pignone, Kevin; Qaqish, Bahjat; Dolor, Rowena J; Turner, Stephanie; Lumpkin, John R; DeWalt, Darren A
发表日期：2025
文献求助 收藏

Efficacy and safety of ultra-rapid lispro versus lispro in children and adolescents with type 1 diabetes: The PRONTO-Peds trial

超速效赖脯胰岛素与赖脯胰岛素治疗1型糖尿病儿童和青少年的疗效和安全性：PRONTO-Peds试验

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14849
Wadwa, R Paul; Laffel, Lori M; Franco, Denise R; Dellva, Mary Anne; Knights, Alastair W; Pollom, Robyn K
代谢
糖尿病
免疫/内分泌
发表日期：2023
文献求助 收藏

Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase study

在一项随机、双盲的早期餐后试验研究中，与优泌乐®相比，超速效赖脯胰岛素（URLi）在1型糖尿病患者中显示出更快的药代动力学和更显著的餐后血糖降低。

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14563
Kazda, Christof; Leohr, Jennifer; Liu, Rong; Reddy, Shobha; Dellva, Mary Anne; Loh, Mei Teng; Hardy, Thomas; Plum-Mörschel, Leona
代谢
糖尿病
免疫/内分泌
发表日期：2022
文献求助 收藏

Ultra-rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early phase study

在一项随机、对照交叉餐后试验早期研究中，与优泌乐®相比，超速效赖脯胰岛素在2型糖尿病患者中显示出更快的药代动力学，并能降低餐后血糖波动。

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14561
Leohr, Jennifer; Kazda, Christof; Liu, Rong; Reddy, Shobha; Dellva, Mary Anne; Matzopoulos, Mark; Loh, Mei Teng; Hardy, Thomas; Klein, Oliver; Kapitza, Christoph
代谢
糖尿病
免疫/内分泌
发表日期：2022
文献求助 收藏

Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs Humalog(®) Consistently Across Study Populations: A Pooled Analysis of Pharmacokinetic and Glucodynamic Data

在所有研究人群中，与优泌乐®相比，超速效赖脯胰岛素 (URLi) 均能持续加速赖脯胰岛素的吸收和胰岛素作用：一项药代动力学和血糖动力学数据的汇总分析

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-021-01030-0
Leohr, Jennifer; Dellva, Mary Anne; Carter, Kallin; LaBell, Elizabeth; Linnebjerg, Helle
免疫/内分泌
发表日期：2021
文献求助 收藏

Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension

超速效赖脯胰岛素（URLi）治疗1型糖尿病成人患者的长期疗效和安全性：PRONTO-T1D扩展研究

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-020-00987-8
Bue-Valleskey, Juliana; Klaff, Leslie; Cho, Jang Ik; Dellva, Mary Anne; Schloot, Nanette C; Tobian, Janet; Miura, Junnosuke; Dahl, Dominik
代谢
糖尿病
免疫/内分泌
发表日期：2021
文献求助 收藏

Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26-week PRONTO-T1D study

与赖脯胰岛素相比，超速效赖脯胰岛素可改善 1 型糖尿病患者的餐后血糖控制：来自为期 26 周的 PRONTO-T1D 研究的结果

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14100
Klaff, Leslie; Cao, Dachuang; Dellva, Mary Anne; Tobian, Janet; Miura, Junnosuke; Dahl, Dominik; Lucas, Jean; Bue-Valleskey, Juliana
代谢
糖尿病
免疫/内分泌
发表日期：2020
文献求助 收藏

Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study

与其他速效胰岛素类似物相比，超速效赖脯胰岛素可降低餐后血糖，并更接近正常的生理血糖反应：一项 1 期随机交叉研究

期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14094
Heise, Tim; Linnebjerg, Helle; Coutant, David; LaBell, Elizabeth; Zijlstra, Eric; Kapitza, Christoph; Bue-Valleskey, Juliana; Zhang, Qianyi; Dellva, Mary Anne; Leohr, Jennifer
免疫/内分泌
发表日期：2020
文献求助 收藏

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial

超速效赖脯胰岛素（URLi）与优泌乐®（赖脯胰岛素）在年轻成人和老年1型糖尿病患者中的药代动力学和血糖动力学比较：一项随机对照试验

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-020-00903-0
Linnebjerg, Helle; Zhang, Qianyi; LaBell, Elizabeth; Dellva, Mary Anne; Coutant, David E; Hövelmann, Ulrike; Plum-Mörschel, Leona; Herbrand, Theresa; Leohr, Jennifer
代谢
糖尿病
免疫/内分泌
发表日期：2020
文献求助 收藏

Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog(®) (Lispro) in Patients with Type 2 Diabetes Mellitus: A Phase I Randomised, Crossover Study

型糖尿病患者中速效赖脯胰岛素 (URLi) 与优泌乐® (赖脯胰岛素) 的药代动力学和血糖动力学比较：一项 I 期随机交叉研究

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-020-00901-2
Leohr, Jennifer; Dellva, Mary Anne; Coutant, David E; LaBell, Elizabeth; Heise, Tim; Andersen, Grit; Zijlstra, Eric; Hermanski, Lidia; Nosek, Leszek; Linnebjerg, Helle
代谢
糖尿病
免疫/内分泌
发表日期：2020
文献求助 收藏